PT-141

$40.00


PT-141, also known as bremelanotide, is a 10 mg research peptide. Review the available lot-specific report in the ECP COA Catalog. For laboratory research only; not for human or veterinary use.

Available

Order within –h –m –s to ship on Monday, November 16.
10:00 AM ET cutoff • In-stock products only
Choose purchase type

LOT-SPECIFIC TESTING

Verified Test Results


Lot-Specific COA

Parameter Result Specification
Appearance


Good

Meets spec
Purity


99.02%
· Pass

≥ 95%
Net Peptide Content


11.21mg

Reported
Identity


Confirmed

Meets spec
Fentanyl Screen


Not Detected

Pass
Heavy Metals


Not Detected

Pass
Sterility


No Growth

Pass
Lot
PT10-0528
Laboratory
Janoshik Analytical

Results shown apply to the listed product lot. Review the full certificate for complete testing information.

Description

PT-141 (Bremelanotide) 10 mg Research Peptide

PT-141, also known as bremelanotide, is offered as a labeled 10 mg laboratory research material.

Research Context

Published structural research has examined bremelanotide in relation to the melanocortin-4 receptor (MC4R). Findings from separately characterized study materials do not establish receptor activity, safety or performance for a specific ECP product lot. Researchers should use appropriate reference materials, controls and validated methods in their own work.

Lot-Specific Documentation

Review the ECP COA Catalog for the available PT-141 report. Results apply only to the identified lot and the tests documented in that report; they should not be interpreted as evidence of unreported tests or biological outcomes.

Explore general research topics in the ECP Research Blog.

Research use only. Not for human or veterinary use. Not intended for consumption, diagnosis, treatment or prevention of disease.

Reviews

There are no reviews yet.

Be the first to review “PT-141”

Your email address will not be published. Required fields are marked *

This product is currently sold out. Don't worry! Enter your email and we'll notify you when it's available again.